Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and crop health science products, and also provides contract manufacturing services.[4] It is a major producer of branded oncology medicines[5] and hepatitis C drugs.[6] The company specialises in producing complex medicines at affordable prices.[7][8] In 2019, Natco launched its crop health sciences division.[9][10]
Company type | Public |
---|---|
NSE: NATCOPHARM BSE: 524816 | |
Industry | Pharmaceuticals |
Founded | 1981 |
Founder | VC Nannapaneni |
Headquarters | , India |
Area served | Global |
Key people | VC Nannapaneni (Chairman and MD)[1] Rajeev Nannapaneni (CEO and Vice Chairman)[2] |
Revenue | ₹2,811 crore (US$350 million) (FY23)[3] |
₹715 crore (US$90 million) (FY23)[3] | |
Website | natcopharma.co.in |